The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis
Viruses · 10.12.2024 · 16 (12) · 1900
DOI: 10.3390/v16121900 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 10.12.2024. Verfasst von Somayeh Komaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California Davis, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immune Evasion, Viral Proteins, Carcinogenesis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, NIAID.
Abstract (Originalsprache)
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a double-stranded DNA gamma herpesvirus. Like other herpesviruses, KSHV establishes a latent infection with limited gene expression, while KSHV occasionally undergoes the lytic replication phase, which produces KSHV progenies and infects neighboring cells. KSHV genome encodes 80+ open reading frames. One of the KSHV genes, K2, encodes viral interleukin 6 (vIL-6), a homolog of human IL-6 (hIL-6), mainly expressed in the lytic phase of the virus. vIL-6 plays a crucial role in regulating the expression of other viral genes and is also associated with inducing angiogenesis, cell survival, and immune evasion, which is suggested to promote the development of KSHV-associated diseases. This review summarizes the current knowledge on vIL-6. We focus on the vIL-6 regarding its protein structure, transcriptional regulation, cell signaling pathways, and contribution to the KSHV-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
ORCID-Profile: Tomoki Inagaki
Förderung
- NCI NIH HHS
- National Institutes of Health, NIAID
Zitieren
APA
Komaki, S., Inagaki, T., Kumar, A., & Izumiya, Y. (2024). The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis. Viruses, 16(12), 1900. https://doi.org/10.3390/v16121900
Vancouver
Komaki S, Inagaki T, Kumar A, Izumiya Y. The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis. Viruses. 2024;16(12):1900. doi:10.3390/v16121900
BibTeX
@article{Komaki2024,
author = {Komaki, Somayeh and Inagaki, Tomoki and Kumar, Ashish and Izumiya, Yoshihiro},
title = {The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis},
journal = {Viruses},
year = {2024},
volume = {16},
number = {12},
pages = {1900},
doi = {10.3390/v16121900}
}
EUVIMED